Literature DB >> 15996892

Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines.

Massimo Locati1, Yeny Martinez de la Torre, Emanuela Galliera, Raffaella Bonecchi, Haribabu Bodduluri, Gianluca Vago, Annunciata Vecchi, Alberto Mantovani.   

Abstract

The chemokine system includes at least three "silent" receptors, DARC, D6 and CCX CKR, with distinct specificity and tissue distribution. D6 binds most inflammatory, but not homeostatic, CC chemokines and shuttles in a ligand-independent way from the plasma membrane to endocytic compartments where chemokines are targeted to degradation. In vitro and in vivo evidence, including results with gene-targeted mice, is consistent with the view that D6 acts as a decoy and scavenger for inflammatory CC chemokines. Thus, D6 has unique functional and structural features, which make it ideally adapted to act as a chemokine decoy and scavenger receptor, strategically located on lymphatic endothelium to dampen inflammation in tissues and draining lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996892     DOI: 10.1016/j.cytogfr.2005.05.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  30 in total

1.  Chemokine decoy receptor D6 in inflammatory bowel disease (IBD) and IBD-associated colon cancer.

Authors:  Colm B Collins; Eoin N McNamee; Joshua D Wermers; Matthew D P Lebsack; Jesús Rivera-Nieves
Journal:  Gut       Date:  2010-02       Impact factor: 23.059

Review 2.  Antiangiogenic therapy in human gastrointestinal malignancies.

Authors:  J Heidemann; D G Binion; W Domschke; T Kucharzik
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

3.  Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6.

Authors:  Yeny Martinez de la Torre; Chiara Buracchi; Elena M Borroni; Jana Dupor; Raffaella Bonecchi; Manuela Nebuloni; Fabio Pasqualini; Andrea Doni; Eleonora Lauri; Chiara Agostinis; Roberta Bulla; Donald N Cook; Bodduluri Haribabu; Pierluigi Meroni; Daniel Rukavina; Luca Vago; Francesco Tedesco; Annunciata Vecchi; Sergio A Lira; Massimo Locati; Alberto Mantovani
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-05       Impact factor: 11.205

Review 4.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

Review 5.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

6.  CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis.

Authors:  Antonio Manzo; Serena Bugatti; Roberto Caporali; Remko Prevo; David G Jackson; Mariagrazia Uguccioni; Christopher D Buckley; Carlomaurizio Montecucco; Costantino Pitzalis
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

7.  CC family chemokines directly regulate myoblast responses to skeletal muscle injury.

Authors:  Linda Yahiaoui; Dusanka Gvozdic; Gawiyou Danialou; Matthias Mack; Basil J Petrof
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

Review 8.  Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology.

Authors:  K E Quinn; D I Mackie; K M Caron
Journal:  Cytokine       Date:  2018-09       Impact factor: 3.861

Review 9.  Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology.

Authors:  Richard M Ransohoff
Journal:  Immunity       Date:  2009-11-20       Impact factor: 31.745

10.  Early immune response following Salmonella enterica subspecies enterica serovar Typhimurium infection in porcine jejunal gut loops.

Authors:  François Meurens; Mustapha Berri; Gael Auray; Sandrine Melo; Benoît Levast; Isabelle Virlogeux-Payant; Claire Chevaleyre; Volker Gerdts; Henri Salmon
Journal:  Vet Res       Date:  2008-10-16       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.